nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—ALB—hepatitis B	0.405	1	CbGaD
Naproxen—SLC22A6—Adefovir Dipivoxil—hepatitis B	0.19	0.63	CbGbCtD
Naproxen—SLC22A6—Lamivudine—hepatitis B	0.112	0.37	CbGbCtD
Naproxen—UGT1A1—blood plasma—hepatitis B	0.00304	0.156	CbGeAlD
Naproxen—Blood creatinine increased—Entecavir—hepatitis B	0.00155	0.00705	CcSEcCtD
Naproxen—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00151	0.00687	CcSEcCtD
Naproxen—Abdominal pain upper—Entecavir—hepatitis B	0.00151	0.00687	CcSEcCtD
Naproxen—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00149	0.00677	CcSEcCtD
Naproxen—Throat sore—Lamivudine—hepatitis B	0.00146	0.00665	CcSEcCtD
Naproxen—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00145	0.0066	CcSEcCtD
Naproxen—CYP2C8—blood plasma—hepatitis B	0.00144	0.0737	CbGeAlD
Naproxen—Renal impairment—Telbivudine—hepatitis B	0.00143	0.00649	CcSEcCtD
Naproxen—Pancreatitis—Entecavir—hepatitis B	0.0014	0.00637	CcSEcCtD
Naproxen—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00137	0.00622	CcSEcCtD
Naproxen—Amblyopia—Lamivudine—hepatitis B	0.00137	0.00621	CcSEcCtD
Naproxen—CYP1A2—blood plasma—hepatitis B	0.00134	0.0689	CbGeAlD
Naproxen—Migraine—Telbivudine—hepatitis B	0.00134	0.00608	CcSEcCtD
Naproxen—Hyperglycaemia—Entecavir—hepatitis B	0.00129	0.00586	CcSEcCtD
Naproxen—CYP2C9—blood plasma—hepatitis B	0.00128	0.0654	CbGeAlD
Naproxen—Blood disorder—Lamivudine—hepatitis B	0.00126	0.00574	CcSEcCtD
Naproxen—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00126	0.00574	CcSEcCtD
Naproxen—Acne—Lamivudine—hepatitis B	0.00125	0.0057	CcSEcCtD
Naproxen—Renal failure—Entecavir—hepatitis B	0.00125	0.0057	CcSEcCtD
Naproxen—Abdominal pain upper—Telbivudine—hepatitis B	0.00124	0.00564	CcSEcCtD
Naproxen—Cramp muscle—Telbivudine—hepatitis B	0.00122	0.00556	CcSEcCtD
Naproxen—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00122	0.00556	CcSEcCtD
Naproxen—Haematuria—Entecavir—hepatitis B	0.00121	0.00553	CcSEcCtD
Naproxen—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00121	0.00551	CcSEcCtD
Naproxen—AKR1C3—blood—hepatitis B	0.00121	0.0619	CbGeAlD
Naproxen—Hepatobiliary disease—Entecavir—hepatitis B	0.0012	0.00548	CcSEcCtD
Naproxen—Gastritis—Telbivudine—hepatitis B	0.0012	0.00547	CcSEcCtD
Naproxen—Vasodilation—Lamivudine—hepatitis B	0.0012	0.00546	CcSEcCtD
Naproxen—Vasodilation procedure—Lamivudine—hepatitis B	0.0012	0.00546	CcSEcCtD
Naproxen—Muscular weakness—Telbivudine—hepatitis B	0.0012	0.00545	CcSEcCtD
Naproxen—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00118	0.00539	CcSEcCtD
Naproxen—Abdominal distension—Telbivudine—hepatitis B	0.00118	0.00538	CcSEcCtD
Naproxen—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00118	0.00535	CcSEcCtD
Naproxen—Influenza—Telbivudine—hepatitis B	0.00117	0.00534	CcSEcCtD
Naproxen—Bone disorder—Lamivudine—hepatitis B	0.00117	0.00531	CcSEcCtD
Naproxen—Rectal haemorrhage—Lamivudine—hepatitis B	0.00117	0.00531	CcSEcCtD
Naproxen—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00117	0.0053	CcSEcCtD
Naproxen—PTGS1—blood plasma—hepatitis B	0.00116	0.0597	CbGeAlD
Naproxen—Oropharyngeal pain—Lamivudine—hepatitis B	0.00116	0.00527	CcSEcCtD
Naproxen—Hepatitis—Entecavir—hepatitis B	0.00114	0.0052	CcSEcCtD
Naproxen—Oedema peripheral—Entecavir—hepatitis B	0.00113	0.00513	CcSEcCtD
Naproxen—Abdominal discomfort—Telbivudine—hepatitis B	0.00113	0.00512	CcSEcCtD
Naproxen—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00112	0.00508	CcSEcCtD
Naproxen—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00111	0.00507	CcSEcCtD
Naproxen—PTGS2—blood plasma—hepatitis B	0.00111	0.0571	CbGeAlD
Naproxen—UGT1A1—blood—hepatitis B	0.00111	0.057	CbGeAlD
Naproxen—Hearing impaired—Lamivudine—hepatitis B	0.00111	0.00504	CcSEcCtD
Naproxen—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00111	0.00504	CcSEcCtD
Naproxen—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0011	0.00501	CcSEcCtD
Naproxen—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0011	0.00499	CcSEcCtD
Naproxen—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00109	0.00498	CcSEcCtD
Naproxen—Inflammation—Lamivudine—hepatitis B	0.00109	0.00494	CcSEcCtD
Naproxen—Vasculitis—Lamivudine—hepatitis B	0.00108	0.00491	CcSEcCtD
Naproxen—Eructation—Lamivudine—hepatitis B	0.00104	0.00471	CcSEcCtD
Naproxen—Immune system disorder—Entecavir—hepatitis B	0.00103	0.0047	CcSEcCtD
Naproxen—Renal failure—Telbivudine—hepatitis B	0.00103	0.00468	CcSEcCtD
Naproxen—Neuropathy peripheral—Telbivudine—hepatitis B	0.00103	0.00467	CcSEcCtD
Naproxen—Wheezing—Lamivudine—hepatitis B	0.00102	0.00466	CcSEcCtD
Naproxen—UGT2B7—liver—hepatitis B	0.00102	0.0525	CbGeAlD
Naproxen—Alopecia—Entecavir—hepatitis B	0.00101	0.0046	CcSEcCtD
Naproxen—Mental disorder—Entecavir—hepatitis B	0.001	0.00456	CcSEcCtD
Naproxen—Malnutrition—Entecavir—hepatitis B	0.000995	0.00453	CcSEcCtD
Naproxen—Aplastic anaemia—Lamivudine—hepatitis B	0.00099	0.0045	CcSEcCtD
Naproxen—Hepatobiliary disease—Telbivudine—hepatitis B	0.00099	0.0045	CcSEcCtD
Naproxen—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000971	0.00442	CcSEcCtD
Naproxen—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000957	0.00435	CcSEcCtD
Naproxen—Mouth ulceration—Lamivudine—hepatitis B	0.000953	0.00434	CcSEcCtD
Naproxen—Urine output increased—Lamivudine—hepatitis B	0.000953	0.00434	CcSEcCtD
Naproxen—AKR1C3—liver—hepatitis B	0.000943	0.0484	CbGeAlD
Naproxen—Hepatitis—Telbivudine—hepatitis B	0.000939	0.00427	CcSEcCtD
Naproxen—Pharyngitis—Telbivudine—hepatitis B	0.000932	0.00424	CcSEcCtD
Naproxen—Connective tissue disorder—Telbivudine—hepatitis B	0.000923	0.0042	CcSEcCtD
Naproxen—Sepsis—Lamivudine—hepatitis B	0.000915	0.00416	CcSEcCtD
Naproxen—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000898	0.00408	CcSEcCtD
Naproxen—Lymphadenopathy—Lamivudine—hepatitis B	0.000897	0.00408	CcSEcCtD
Naproxen—Leukopenia—Entecavir—hepatitis B	0.000891	0.00405	CcSEcCtD
Naproxen—Polyuria—Lamivudine—hepatitis B	0.000871	0.00397	CcSEcCtD
Naproxen—UGT1A1—liver—hepatitis B	0.00087	0.0446	CbGeAlD
Naproxen—Gastroenteritis—Lamivudine—hepatitis B	0.000863	0.00393	CcSEcCtD
Naproxen—Deafness—Lamivudine—hepatitis B	0.000855	0.00389	CcSEcCtD
Naproxen—Cough—Adefovir Dipivoxil—hepatitis B	0.000847	0.00386	CcSEcCtD
Naproxen—Mediastinal disorder—Telbivudine—hepatitis B	0.000847	0.00385	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000842	0.00383	CcSEcCtD
Naproxen—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000827	0.00376	CcSEcCtD
Naproxen—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000827	0.00376	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000821	0.00374	CcSEcCtD
Naproxen—Malnutrition—Telbivudine—hepatitis B	0.000818	0.00372	CcSEcCtD
Naproxen—Anaphylactic shock—Entecavir—hepatitis B	0.000812	0.0037	CcSEcCtD
Naproxen—Infection—Entecavir—hepatitis B	0.000807	0.00367	CcSEcCtD
Naproxen—Renal impairment—Lamivudine—hepatitis B	0.000804	0.00366	CcSEcCtD
Naproxen—Thirst—Lamivudine—hepatitis B	0.000804	0.00366	CcSEcCtD
Naproxen—Nervous system disorder—Entecavir—hepatitis B	0.000797	0.00362	CcSEcCtD
Naproxen—Skin disorder—Entecavir—hepatitis B	0.000789	0.00359	CcSEcCtD
Naproxen—Muscle spasms—Telbivudine—hepatitis B	0.000786	0.00358	CcSEcCtD
Naproxen—Hypoglycaemia—Lamivudine—hepatitis B	0.000784	0.00357	CcSEcCtD
Naproxen—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000777	0.00354	CcSEcCtD
Naproxen—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000776	0.00353	CcSEcCtD
Naproxen—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00077	0.0035	CcSEcCtD
Naproxen—Ill-defined disorder—Telbivudine—hepatitis B	0.000759	0.00345	CcSEcCtD
Naproxen—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000756	0.00344	CcSEcCtD
Naproxen—Affect lability—Lamivudine—hepatitis B	0.000753	0.00343	CcSEcCtD
Naproxen—Migraine—Lamivudine—hepatitis B	0.000753	0.00343	CcSEcCtD
Naproxen—Malaise—Telbivudine—hepatitis B	0.000737	0.00336	CcSEcCtD
Naproxen—Insomnia—Entecavir—hepatitis B	0.000735	0.00334	CcSEcCtD
Naproxen—Mood swings—Lamivudine—hepatitis B	0.000725	0.0033	CcSEcCtD
Naproxen—Somnolence—Entecavir—hepatitis B	0.000722	0.00329	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000722	0.00329	CcSEcCtD
Naproxen—Dyspepsia—Entecavir—hepatitis B	0.000715	0.00325	CcSEcCtD
Naproxen—Cough—Telbivudine—hepatitis B	0.000714	0.00325	CcSEcCtD
Naproxen—Dehydration—Lamivudine—hepatitis B	0.000712	0.00324	CcSEcCtD
Naproxen—Liver function test abnormal—Lamivudine—hepatitis B	0.000706	0.00321	CcSEcCtD
Naproxen—Gastrointestinal disorder—Entecavir—hepatitis B	0.000701	0.00319	CcSEcCtD
Naproxen—Fatigue—Entecavir—hepatitis B	0.0007	0.00319	CcSEcCtD
Naproxen—Abdominal pain upper—Lamivudine—hepatitis B	0.000699	0.00318	CcSEcCtD
Naproxen—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000698	0.00317	CcSEcCtD
Naproxen—Chest pain—Telbivudine—hepatitis B	0.000696	0.00317	CcSEcCtD
Naproxen—Myalgia—Telbivudine—hepatitis B	0.000696	0.00317	CcSEcCtD
Naproxen—Arthralgia—Telbivudine—hepatitis B	0.000696	0.00317	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000691	0.00315	CcSEcCtD
Naproxen—Cramp muscle—Lamivudine—hepatitis B	0.000689	0.00314	CcSEcCtD
Naproxen—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000689	0.00313	CcSEcCtD
Naproxen—Discomfort—Telbivudine—hepatitis B	0.000688	0.00313	CcSEcCtD
Naproxen—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000684	0.00311	CcSEcCtD
Naproxen—Muscular weakness—Lamivudine—hepatitis B	0.000675	0.00307	CcSEcCtD
Naproxen—Abdominal distension—Lamivudine—hepatitis B	0.000666	0.00303	CcSEcCtD
Naproxen—Gastrointestinal pain—Entecavir—hepatitis B	0.000664	0.00302	CcSEcCtD
Naproxen—Dysphagia—Lamivudine—hepatitis B	0.000661	0.00301	CcSEcCtD
Naproxen—Influenza—Lamivudine—hepatitis B	0.000661	0.00301	CcSEcCtD
Naproxen—Nervous system disorder—Telbivudine—hepatitis B	0.000654	0.00298	CcSEcCtD
Naproxen—Thrombocytopenia—Telbivudine—hepatitis B	0.000653	0.00297	CcSEcCtD
Naproxen—Pancreatitis—Lamivudine—hepatitis B	0.000648	0.00295	CcSEcCtD
Naproxen—Skin disorder—Telbivudine—hepatitis B	0.000648	0.00295	CcSEcCtD
Naproxen—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000648	0.00295	CcSEcCtD
Naproxen—Abdominal pain—Entecavir—hepatitis B	0.000642	0.00292	CcSEcCtD
Naproxen—Body temperature increased—Entecavir—hepatitis B	0.000642	0.00292	CcSEcCtD
Naproxen—Bronchitis—Lamivudine—hepatitis B	0.000636	0.00289	CcSEcCtD
Naproxen—Abdominal discomfort—Lamivudine—hepatitis B	0.000634	0.00288	CcSEcCtD
Naproxen—Pancytopenia—Lamivudine—hepatitis B	0.000628	0.00286	CcSEcCtD
Naproxen—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000627	0.00285	CcSEcCtD
Naproxen—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000627	0.00285	CcSEcCtD
Naproxen—Dysuria—Lamivudine—hepatitis B	0.000618	0.00281	CcSEcCtD
Naproxen—Pollakiuria—Lamivudine—hepatitis B	0.000611	0.00278	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000608	0.00277	CcSEcCtD
Naproxen—Insomnia—Telbivudine—hepatitis B	0.000604	0.00275	CcSEcCtD
Naproxen—Paraesthesia—Telbivudine—hepatitis B	0.000599	0.00273	CcSEcCtD
Naproxen—Hyperglycaemia—Lamivudine—hepatitis B	0.000597	0.00271	CcSEcCtD
Naproxen—SLCO1A2—liver—hepatitis B	0.000589	0.0302	CbGeAlD
Naproxen—Depression—Lamivudine—hepatitis B	0.000588	0.00268	CcSEcCtD
Naproxen—Dyspepsia—Telbivudine—hepatitis B	0.000587	0.00267	CcSEcCtD
Naproxen—ALB—liver—hepatitis B	0.000585	0.03	CbGeAlD
Naproxen—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000585	0.00266	CcSEcCtD
Naproxen—Asthenia—Entecavir—hepatitis B	0.000583	0.00265	CcSEcCtD
Naproxen—Renal failure—Lamivudine—hepatitis B	0.00058	0.00264	CcSEcCtD
Naproxen—Neuropathy peripheral—Lamivudine—hepatitis B	0.000578	0.00263	CcSEcCtD
Naproxen—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000576	0.00262	CcSEcCtD
Naproxen—Fatigue—Telbivudine—hepatitis B	0.000575	0.00262	CcSEcCtD
Naproxen—Stomatitis—Lamivudine—hepatitis B	0.000575	0.00262	CcSEcCtD
Naproxen—Jaundice—Lamivudine—hepatitis B	0.000575	0.00262	CcSEcCtD
Naproxen—Pain—Telbivudine—hepatitis B	0.000571	0.0026	CcSEcCtD
Naproxen—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000569	0.00259	CcSEcCtD
Naproxen—Sweating—Lamivudine—hepatitis B	0.000565	0.00257	CcSEcCtD
Naproxen—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000561	0.00255	CcSEcCtD
Naproxen—Hepatobiliary disease—Lamivudine—hepatitis B	0.000558	0.00254	CcSEcCtD
Naproxen—Epistaxis—Lamivudine—hepatitis B	0.000556	0.00253	CcSEcCtD
Naproxen—Diarrhoea—Entecavir—hepatitis B	0.000556	0.00253	CcSEcCtD
Naproxen—Sinusitis—Lamivudine—hepatitis B	0.000553	0.00252	CcSEcCtD
Naproxen—Agranulocytosis—Lamivudine—hepatitis B	0.00055	0.0025	CcSEcCtD
Naproxen—Feeling abnormal—Telbivudine—hepatitis B	0.00055	0.0025	CcSEcCtD
Naproxen—Gastrointestinal pain—Telbivudine—hepatitis B	0.000546	0.00248	CcSEcCtD
Naproxen—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000542	0.00247	CcSEcCtD
Naproxen—Dizziness—Entecavir—hepatitis B	0.000537	0.00244	CcSEcCtD
Naproxen—Rhinitis—Lamivudine—hepatitis B	0.000531	0.00241	CcSEcCtD
Naproxen—Hepatitis—Lamivudine—hepatitis B	0.000529	0.00241	CcSEcCtD
Naproxen—Body temperature increased—Telbivudine—hepatitis B	0.000528	0.0024	CcSEcCtD
Naproxen—Abdominal pain—Telbivudine—hepatitis B	0.000528	0.0024	CcSEcCtD
Naproxen—CYP2C8—blood—hepatitis B	0.000526	0.027	CbGeAlD
Naproxen—Pharyngitis—Lamivudine—hepatitis B	0.000525	0.00239	CcSEcCtD
Naproxen—Connective tissue disorder—Lamivudine—hepatitis B	0.00052	0.00237	CcSEcCtD
Naproxen—Vomiting—Entecavir—hepatitis B	0.000517	0.00235	CcSEcCtD
Naproxen—Rash—Entecavir—hepatitis B	0.000512	0.00233	CcSEcCtD
Naproxen—Dermatitis—Entecavir—hepatitis B	0.000512	0.00233	CcSEcCtD
Naproxen—Headache—Entecavir—hepatitis B	0.000509	0.00232	CcSEcCtD
Naproxen—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000504	0.00229	CcSEcCtD
Naproxen—Erythema multiforme—Lamivudine—hepatitis B	0.000501	0.00228	CcSEcCtD
Naproxen—Rash—Adefovir Dipivoxil—hepatitis B	0.0005	0.00227	CcSEcCtD
Naproxen—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000499	0.00227	CcSEcCtD
Naproxen—Headache—Adefovir Dipivoxil—hepatitis B	0.000497	0.00226	CcSEcCtD
Naproxen—CYP1A2—blood—hepatitis B	0.000492	0.0253	CbGeAlD
Naproxen—Nausea—Entecavir—hepatitis B	0.000483	0.0022	CcSEcCtD
Naproxen—Asthenia—Telbivudine—hepatitis B	0.000479	0.00218	CcSEcCtD
Naproxen—Immune system disorder—Lamivudine—hepatitis B	0.000478	0.00218	CcSEcCtD
Naproxen—Mediastinal disorder—Lamivudine—hepatitis B	0.000477	0.00217	CcSEcCtD
Naproxen—Chills—Lamivudine—hepatitis B	0.000475	0.00216	CcSEcCtD
Naproxen—Pruritus—Telbivudine—hepatitis B	0.000472	0.00215	CcSEcCtD
Naproxen—Nausea—Adefovir Dipivoxil—hepatitis B	0.000471	0.00214	CcSEcCtD
Naproxen—Alopecia—Lamivudine—hepatitis B	0.000468	0.00213	CcSEcCtD
Naproxen—CYP2C9—blood—hepatitis B	0.000467	0.024	CbGeAlD
Naproxen—Malnutrition—Lamivudine—hepatitis B	0.000461	0.0021	CcSEcCtD
Naproxen—Erythema—Lamivudine—hepatitis B	0.000461	0.0021	CcSEcCtD
Naproxen—Diarrhoea—Telbivudine—hepatitis B	0.000457	0.00208	CcSEcCtD
Naproxen—Fenoprofen—ALB—hepatitis B	0.000455	0.281	CrCbGaD
Naproxen—Flatulence—Lamivudine—hepatitis B	0.000454	0.00207	CcSEcCtD
Naproxen—Tension—Lamivudine—hepatitis B	0.000452	0.00206	CcSEcCtD
Naproxen—Nervousness—Lamivudine—hepatitis B	0.000448	0.00204	CcSEcCtD
Naproxen—Muscle spasms—Lamivudine—hepatitis B	0.000443	0.00202	CcSEcCtD
Naproxen—Dizziness—Telbivudine—hepatitis B	0.000441	0.00201	CcSEcCtD
Naproxen—Tremor—Lamivudine—hepatitis B	0.000432	0.00196	CcSEcCtD
Naproxen—Ill-defined disorder—Lamivudine—hepatitis B	0.000428	0.00195	CcSEcCtD
Naproxen—PTGS1—blood—hepatitis B	0.000427	0.0219	CbGeAlD
Naproxen—Anaemia—Lamivudine—hepatitis B	0.000426	0.00194	CcSEcCtD
Naproxen—Vomiting—Telbivudine—hepatitis B	0.000424	0.00193	CcSEcCtD
Naproxen—Angioedema—Lamivudine—hepatitis B	0.000421	0.00192	CcSEcCtD
Naproxen—Rash—Telbivudine—hepatitis B	0.000421	0.00191	CcSEcCtD
Naproxen—Dermatitis—Telbivudine—hepatitis B	0.00042	0.00191	CcSEcCtD
Naproxen—Headache—Telbivudine—hepatitis B	0.000418	0.0019	CcSEcCtD
Naproxen—Malaise—Lamivudine—hepatitis B	0.000416	0.00189	CcSEcCtD
Naproxen—Vertigo—Lamivudine—hepatitis B	0.000414	0.00188	CcSEcCtD
Naproxen—Syncope—Lamivudine—hepatitis B	0.000413	0.00188	CcSEcCtD
Naproxen—Leukopenia—Lamivudine—hepatitis B	0.000413	0.00188	CcSEcCtD
Naproxen—CYP2C8—liver—hepatitis B	0.000411	0.0211	CbGeAlD
Naproxen—PTGS2—blood—hepatitis B	0.000408	0.0209	CbGeAlD
Naproxen—Loss of consciousness—Lamivudine—hepatitis B	0.000405	0.00184	CcSEcCtD
Naproxen—Cough—Lamivudine—hepatitis B	0.000402	0.00183	CcSEcCtD
Naproxen—Convulsion—Lamivudine—hepatitis B	0.000399	0.00182	CcSEcCtD
Naproxen—Nausea—Telbivudine—hepatitis B	0.000396	0.0018	CcSEcCtD
Naproxen—Arthralgia—Lamivudine—hepatitis B	0.000392	0.00179	CcSEcCtD
Naproxen—Chest pain—Lamivudine—hepatitis B	0.000392	0.00179	CcSEcCtD
Naproxen—Myalgia—Lamivudine—hepatitis B	0.000392	0.00179	CcSEcCtD
Naproxen—Anxiety—Lamivudine—hepatitis B	0.000391	0.00178	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00039	0.00177	CcSEcCtD
Naproxen—Discomfort—Lamivudine—hepatitis B	0.000388	0.00176	CcSEcCtD
Naproxen—CYP1A2—liver—hepatitis B	0.000385	0.0198	CbGeAlD
Naproxen—Dry mouth—Lamivudine—hepatitis B	0.000384	0.00175	CcSEcCtD
Naproxen—Confusional state—Lamivudine—hepatitis B	0.000379	0.00173	CcSEcCtD
Naproxen—Oedema—Lamivudine—hepatitis B	0.000376	0.00171	CcSEcCtD
Naproxen—Anaphylactic shock—Lamivudine—hepatitis B	0.000376	0.00171	CcSEcCtD
Naproxen—Infection—Lamivudine—hepatitis B	0.000374	0.0017	CcSEcCtD
Naproxen—Shock—Lamivudine—hepatitis B	0.00037	0.00168	CcSEcCtD
Naproxen—Nervous system disorder—Lamivudine—hepatitis B	0.000369	0.00168	CcSEcCtD
Naproxen—Thrombocytopenia—Lamivudine—hepatitis B	0.000368	0.00168	CcSEcCtD
Naproxen—CYP2C9—liver—hepatitis B	0.000365	0.0187	CbGeAlD
Naproxen—Skin disorder—Lamivudine—hepatitis B	0.000365	0.00166	CcSEcCtD
Naproxen—Hyperhidrosis—Lamivudine—hepatitis B	0.000364	0.00165	CcSEcCtD
Naproxen—Anorexia—Lamivudine—hepatitis B	0.000359	0.00163	CcSEcCtD
Naproxen—Hypotension—Lamivudine—hepatitis B	0.000351	0.0016	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000343	0.00156	CcSEcCtD
Naproxen—Insomnia—Lamivudine—hepatitis B	0.00034	0.00155	CcSEcCtD
Naproxen—Paraesthesia—Lamivudine—hepatitis B	0.000338	0.00154	CcSEcCtD
Naproxen—Indomethacin—ALB—hepatitis B	0.000335	0.207	CrCbGaD
Naproxen—Dyspnoea—Lamivudine—hepatitis B	0.000335	0.00153	CcSEcCtD
Naproxen—Somnolence—Lamivudine—hepatitis B	0.000334	0.00152	CcSEcCtD
Naproxen—Dyspepsia—Lamivudine—hepatitis B	0.000331	0.00151	CcSEcCtD
Naproxen—Decreased appetite—Lamivudine—hepatitis B	0.000327	0.00149	CcSEcCtD
Naproxen—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000325	0.00148	CcSEcCtD
Naproxen—Fatigue—Lamivudine—hepatitis B	0.000324	0.00148	CcSEcCtD
Naproxen—Pain—Lamivudine—hepatitis B	0.000322	0.00146	CcSEcCtD
Naproxen—Constipation—Lamivudine—hepatitis B	0.000322	0.00146	CcSEcCtD
Naproxen—PTGS2—liver—hepatitis B	0.000319	0.0164	CbGeAlD
Naproxen—Feeling abnormal—Lamivudine—hepatitis B	0.00031	0.00141	CcSEcCtD
Naproxen—Gastrointestinal pain—Lamivudine—hepatitis B	0.000308	0.0014	CcSEcCtD
Naproxen—Urticaria—Lamivudine—hepatitis B	0.000299	0.00136	CcSEcCtD
Naproxen—Body temperature increased—Lamivudine—hepatitis B	0.000297	0.00135	CcSEcCtD
Naproxen—Abdominal pain—Lamivudine—hepatitis B	0.000297	0.00135	CcSEcCtD
Naproxen—Flurbiprofen—ALB—hepatitis B	0.000297	0.183	CrCbGaD
Naproxen—Hypersensitivity—Lamivudine—hepatitis B	0.000277	0.00126	CcSEcCtD
Naproxen—Asthenia—Lamivudine—hepatitis B	0.00027	0.00123	CcSEcCtD
Naproxen—Ketoprofen—ALB—hepatitis B	0.000268	0.166	CrCbGaD
Naproxen—Pruritus—Lamivudine—hepatitis B	0.000266	0.00121	CcSEcCtD
Naproxen—Ibuprofen—ALB—hepatitis B	0.000264	0.163	CrCbGaD
Naproxen—Diarrhoea—Lamivudine—hepatitis B	0.000257	0.00117	CcSEcCtD
Naproxen—Dizziness—Lamivudine—hepatitis B	0.000249	0.00113	CcSEcCtD
Naproxen—Vomiting—Lamivudine—hepatitis B	0.000239	0.00109	CcSEcCtD
Naproxen—Rash—Lamivudine—hepatitis B	0.000237	0.00108	CcSEcCtD
Naproxen—Dermatitis—Lamivudine—hepatitis B	0.000237	0.00108	CcSEcCtD
Naproxen—Headache—Lamivudine—hepatitis B	0.000236	0.00107	CcSEcCtD
Naproxen—Nausea—Lamivudine—hepatitis B	0.000223	0.00102	CcSEcCtD
Naproxen—AKR1C3—Disease—APOBEC3G—hepatitis B	0.000155	0.00296	CbGpPWpGaD
Naproxen—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000154	0.00296	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00015	0.00288	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.00015	0.00288	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00015	0.00287	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—GGT1—hepatitis B	0.000148	0.00284	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.000148	0.00284	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—F2—hepatitis B	0.000147	0.00282	CbGpPWpGaD
Naproxen—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000146	0.00281	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—hepatitis B	0.00014	0.00268	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CXCL10—hepatitis B	0.00014	0.00268	CbGpPWpGaD
Naproxen—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000135	0.00259	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000134	0.00258	CbGpPWpGaD
Naproxen—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000132	0.00253	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000128	0.00246	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000125	0.0024	CbGpPWpGaD
Naproxen—ALB—Hemostasis—HBE1—hepatitis B	0.000125	0.0024	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000124	0.00239	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—hepatitis B	0.000124	0.00238	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000123	0.00236	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—F2—hepatitis B	0.00012	0.00229	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000119	0.00229	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—F2—hepatitis B	0.000117	0.00225	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—AKR1B1—hepatitis B	0.000117	0.00224	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000114	0.00219	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GGT2—hepatitis B	0.000112	0.00215	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.000112	0.00215	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000112	0.00214	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	0.000111	0.00214	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RIT2—hepatitis B	0.000108	0.00208	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SAG—hepatitis B	0.000108	0.00208	CbGpPWpGaD
Naproxen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.000106	0.00204	CbGpPWpGaD
Naproxen—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000104	0.00199	CbGpPWpGaD
Naproxen—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000102	0.00195	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—ALB—hepatitis B	9.75e-05	0.00187	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	9.68e-05	0.00186	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TLR4—hepatitis B	9.64e-05	0.00185	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—F2—hepatitis B	9.5e-05	0.00182	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—CDKN2A—hepatitis B	9.47e-05	0.00182	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	9.33e-05	0.00179	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	9.27e-05	0.00178	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—NOS2—hepatitis B	9.17e-05	0.00176	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	9.1e-05	0.00174	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	9.08e-05	0.00174	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IFNG—hepatitis B	9.06e-05	0.00174	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	9.05e-05	0.00174	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—CD4—hepatitis B	8.92e-05	0.00171	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IFNG—hepatitis B	8.9e-05	0.00171	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—GGT1—hepatitis B	8.73e-05	0.00167	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	8.46e-05	0.00162	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	8.41e-05	0.00161	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL2—hepatitis B	8.05e-05	0.00154	CbGpPWpGaD
Naproxen—UGT2B7—NRF2 pathway—TGFB1—hepatitis B	7.82e-05	0.0015	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	7.77e-05	0.00149	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	7.74e-05	0.00148	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—AKR1B1—hepatitis B	7.69e-05	0.00147	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	7.57e-05	0.00145	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—NFKB1—hepatitis B	7.54e-05	0.00145	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	7.52e-05	0.00144	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	7.4e-05	0.00142	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	7.39e-05	0.00142	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GGT2—hepatitis B	7.37e-05	0.00141	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	7.35e-05	0.00141	CbGpPWpGaD
Naproxen—AKR1C3—Disease—GOT2—hepatitis B	7.34e-05	0.00141	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	7.3e-05	0.0014	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	7.25e-05	0.00139	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	7.21e-05	0.00138	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	7.2e-05	0.00138	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—GGT1—hepatitis B	7.1e-05	0.00136	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	7.09e-05	0.00136	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	7.04e-05	0.00135	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	7.04e-05	0.00135	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.82e-05	0.00131	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CYP2A6—hepatitis B	6.8e-05	0.0013	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—ALB—hepatitis B	6.79e-05	0.0013	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—AKR1B1—hepatitis B	6.7e-05	0.00128	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GGT2—hepatitis B	6.42e-05	0.00123	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—ALB—hepatitis B	6.38e-05	0.00122	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—TGFB1—hepatitis B	6.36e-05	0.00122	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.34e-05	0.00122	CbGpPWpGaD
Naproxen—AKR1C3—Disease—GOT1—hepatitis B	6.34e-05	0.00122	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL2—hepatitis B	6.25e-05	0.0012	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—AKR1B1—hepatitis B	6.25e-05	0.0012	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GOT2—hepatitis B	6.15e-05	0.00118	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GGT1—hepatitis B	6.07e-05	0.00116	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	6.01e-05	0.00115	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GGT2—hepatitis B	5.99e-05	0.00115	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	5.99e-05	0.00115	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—hepatitis B	5.86e-05	0.00112	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	5.86e-05	0.00112	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	5.85e-05	0.00112	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	5.82e-05	0.00112	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	5.76e-05	0.0011	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	5.48e-05	0.00105	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	5.48e-05	0.00105	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—TGFB1—hepatitis B	5.38e-05	0.00103	CbGpPWpGaD
Naproxen—PTGS2—Disease—SAG—hepatitis B	5.34e-05	0.00102	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOBEC3G—hepatitis B	5.34e-05	0.00102	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GGT1—hepatitis B	5.31e-05	0.00102	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GOT1—hepatitis B	5.31e-05	0.00102	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.19e-05	0.000995	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TP53—hepatitis B	5.17e-05	0.000991	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.14e-05	0.000985	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	5.13e-05	0.000984	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AKR1B1—hepatitis B	5.09e-05	0.000977	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GGT2—hepatitis B	4.88e-05	0.000937	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	4.88e-05	0.000935	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.84e-05	0.000927	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—hepatitis B	4.73e-05	0.000908	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CCR5—hepatitis B	4.73e-05	0.000907	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—hepatitis B	4.66e-05	0.000893	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	4.65e-05	0.000891	CbGpPWpGaD
Naproxen—AKR1C3—Disease—HLA-A—hepatitis B	4.61e-05	0.000884	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—hepatitis B	4.55e-05	0.000873	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	4.55e-05	0.000872	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP2A6—hepatitis B	4.47e-05	0.000857	CbGpPWpGaD
Naproxen—ALB—Hemostasis—HSPA5—hepatitis B	4.34e-05	0.000832	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL10—hepatitis B	4.27e-05	0.000819	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.12e-05	0.00079	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	4.11e-05	0.000787	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKR1B1—hepatitis B	4.04e-05	0.000776	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GOT2—hepatitis B	4.04e-05	0.000775	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TP53—hepatitis B	4.01e-05	0.00077	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	4.01e-05	0.000769	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS2—hepatitis B	4.01e-05	0.000769	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	4e-05	0.000767	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	3.98e-05	0.000764	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IFNB1—hepatitis B	3.91e-05	0.00075	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP2A6—hepatitis B	3.89e-05	0.000746	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GGT2—hepatitis B	3.88e-05	0.000744	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IFNA1—hepatitis B	3.82e-05	0.000732	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—hepatitis B	3.76e-05	0.000721	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—hepatitis B	3.68e-05	0.000705	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP2A6—hepatitis B	3.63e-05	0.000696	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.63e-05	0.000696	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IFNA2—hepatitis B	3.55e-05	0.000681	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GOT2—hepatitis B	3.52e-05	0.000675	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GOT1—hepatitis B	3.49e-05	0.000669	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GGT1—hepatitis B	3.49e-05	0.000669	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ALB—hepatitis B	3.45e-05	0.000661	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.35e-05	0.000643	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.33e-05	0.000639	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.32e-05	0.000636	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCR5—hepatitis B	3.31e-05	0.000635	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKR1B1—hepatitis B	3.29e-05	0.000631	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GOT2—hepatitis B	3.28e-05	0.00063	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKR1B1—hepatitis B	3.27e-05	0.000627	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ALB—hepatitis B	3.24e-05	0.000622	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGT2—hepatitis B	3.15e-05	0.000605	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGT2—hepatitis B	3.14e-05	0.000602	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.1e-05	0.000594	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	3.06e-05	0.000587	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GGT1—hepatitis B	3.04e-05	0.000582	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GOT1—hepatitis B	3.04e-05	0.000582	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD4—hepatitis B	2.97e-05	0.00057	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP2A6—hepatitis B	2.96e-05	0.000567	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—F2—hepatitis B	2.84e-05	0.000545	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GGT1—hepatitis B	2.83e-05	0.000543	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GOT1—hepatitis B	2.83e-05	0.000543	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ALB—hepatitis B	2.82e-05	0.000541	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.77e-05	0.000531	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.76e-05	0.000529	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.73e-05	0.000524	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.73e-05	0.000523	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKR1B1—hepatitis B	2.68e-05	0.000514	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GOT2—hepatitis B	2.68e-05	0.000513	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CTNNB1—hepatitis B	2.64e-05	0.000506	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CDKN1A—hepatitis B	2.58e-05	0.000494	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PTEN—hepatitis B	2.57e-05	0.000493	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGT2—hepatitis B	2.57e-05	0.000492	CbGpPWpGaD
Naproxen—PTGS2—Disease—GOT2—hepatitis B	2.54e-05	0.000486	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	2.39e-05	0.000458	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP2A6—hepatitis B	2.35e-05	0.00045	CbGpPWpGaD
Naproxen—ALB—Hemostasis—F2—hepatitis B	2.34e-05	0.000449	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.33e-05	0.000447	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS2—hepatitis B	2.32e-05	0.000444	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GOT1—hepatitis B	2.31e-05	0.000443	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GGT1—hepatitis B	2.31e-05	0.000443	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKR1B1—hepatitis B	2.29e-05	0.000439	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGT2—hepatitis B	2.19e-05	0.000421	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.19e-05	0.00042	CbGpPWpGaD
Naproxen—PTGS2—Disease—GOT1—hepatitis B	2.19e-05	0.00042	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTEN—hepatitis B	2.15e-05	0.000413	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TGFB1—hepatitis B	2.13e-05	0.000409	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GOT2—hepatitis B	2.12e-05	0.000407	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.11e-05	0.000404	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2—hepatitis B	1.91e-05	0.000367	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP2A6—hepatitis B	1.91e-05	0.000367	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP2A6—hepatitis B	1.9e-05	0.000364	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—hepatitis B	1.85e-05	0.000356	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CTNNB1—hepatitis B	1.85e-05	0.000354	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GOT1—hepatitis B	1.83e-05	0.000352	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GGT1—hepatitis B	1.83e-05	0.000352	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN1A—hepatitis B	1.81e-05	0.000346	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PTEN—hepatitis B	1.8e-05	0.000345	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NFKB1—hepatitis B	1.79e-05	0.000344	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.78e-05	0.000342	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT2—hepatitis B	1.73e-05	0.000331	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT2—hepatitis B	1.72e-05	0.00033	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.67e-05	0.00032	CbGpPWpGaD
Naproxen—PTGS2—Disease—CCR5—hepatitis B	1.63e-05	0.000313	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—hepatitis B	1.62e-05	0.00031	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—hepatitis B	1.61e-05	0.000308	CbGpPWpGaD
Naproxen—PTGS2—Disease—HLA-A—hepatitis B	1.59e-05	0.000305	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2—hepatitis B	1.58e-05	0.000303	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.56e-05	0.000298	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—hepatitis B	1.51e-05	0.000289	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—hepatitis B	1.49e-05	0.000286	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGT1—hepatitis B	1.49e-05	0.000286	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT1—hepatitis B	1.49e-05	0.000286	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT1—hepatitis B	1.48e-05	0.000285	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGT1—hepatitis B	1.48e-05	0.000285	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.45e-05	0.000278	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTEN—hepatitis B	1.42e-05	0.000271	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT2—hepatitis B	1.41e-05	0.00027	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—hepatitis B	1.39e-05	0.000266	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.36e-05	0.000261	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.35e-05	0.000259	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2A6—hepatitis B	1.33e-05	0.000255	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.24e-05	0.000238	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTEN—hepatitis B	1.23e-05	0.000236	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—hepatitis B	1.23e-05	0.000236	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TP53—hepatitis B	1.23e-05	0.000236	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—hepatitis B	1.23e-05	0.000236	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGT1—hepatitis B	1.21e-05	0.000233	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT1—hepatitis B	1.21e-05	0.000233	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT2—hepatitis B	1.2e-05	0.000231	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTEN—hepatitis B	1.15e-05	0.000221	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—hepatitis B	1.13e-05	0.000216	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.11e-05	0.000212	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGT1—hepatitis B	1.04e-05	0.000199	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT1—hepatitis B	1.04e-05	0.000199	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD4—hepatitis B	1.03e-05	0.000197	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TP53—hepatitis B	1.01e-05	0.000194	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—hepatitis B	9.75e-06	0.000187	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.46e-06	0.000181	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTEN—hepatitis B	9.37e-06	0.00018	CbGpPWpGaD
Naproxen—PTGS2—Disease—CTNNB1—hepatitis B	9.12e-06	0.000175	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN1A—hepatitis B	8.91e-06	0.000171	CbGpPWpGaD
Naproxen—PTGS2—Disease—PTEN—hepatitis B	8.89e-06	0.00017	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—hepatitis B	7.94e-06	0.000152	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PTEN—hepatitis B	7.44e-06	0.000143	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—hepatitis B	7.37e-06	0.000141	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—hepatitis B	6.46e-06	0.000124	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTEN—hepatitis B	6.06e-06	0.000116	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTEN—hepatitis B	6.02e-06	0.000115	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—hepatitis B	5.55e-06	0.000106	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—hepatitis B	5.52e-06	0.000106	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTEN—hepatitis B	4.93e-06	9.45e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTEN—hepatitis B	4.21e-06	8.08e-05	CbGpPWpGaD
